Evaluation of Analytical Performance Specifications for Clinical Laboratory Tests Based on Test Misclassification
The Journal of Applied Laboratory Medicine · 2026
DOI: 10.1093/jalm/jfag030 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Qian Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States. Hauptthemen laut MEDLINE: Laboratories, Clinical, Clinical Laboratory Techniques, Quality Assurance, Health Care, Diagnostic Errors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Analytical performance specifications for laboratory tests are essential components of quality assurance for clinical laboratories. A widely adopted performance criterion is total allowable error (TEa), which includes contributions from both bias and imprecision, which may contribute to test inaccuracies. However, the relationship of TEa to test result misclassification, a clinically relevant quality measure, is unclear.
Methods
Hypothetical clinical laboratory test results for 4 test models were generated and subjected to proportional bias and imprecision. Test misclassification (TM) as a function of bias and imprecision was determined using pre-defined cutpoint(s). Simulation analyses were then performed on 14 chemistry analytes using 3 data sets from patient results reported at the National Institutes of Health (NIH).
Results
We observed a complex and nonlinear relationship between bias and imprecision, and their impact on TM was not additive as may have been expected with TEa. TM scores were influenced by population distribution, the location of cutpoints, and the fraction of abnormal test values at baseline. Stringent TEa requirements did not correspond to low TM scores. On the contrary, TM scores for electrolytes were among the highest. Instead, TM scores closely correlated with the ratio of TEa to the width of the population distribution.
Conclusion
TM has the advantage of correctly accounting for the differential effects of bias and imprecision. Compared to TEa, it provides a more accessible metric for evaluating performance and the clinical impact of errors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States.
- Department of Pathology and Laboratory Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI, United States.
- Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School of Medicine, Auburn Hills, MI, United States.
- Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Zitieren
APA
Sun, Q., Sampson, M., Auger, C., Remaley, A. T., & Harb, R. (2026). Evaluation of Analytical Performance Specifications for Clinical Laboratory Tests Based on Test Misclassification. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfag030
Vancouver
Sun Q, Sampson M, Auger C, Remaley AT, Harb R. Evaluation of Analytical Performance Specifications for Clinical Laboratory Tests Based on Test Misclassification. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfag030
BibTeX
@article{Sun2026,
author = {Sun, Qian and Sampson, Maureen and Auger, Claire and Remaley, Alan T and Harb, Roa},
title = {Evaluation of Analytical Performance Specifications for Clinical Laboratory Tests Based on Test Misclassification},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
doi = {10.1093/jalm/jfag030}
}
EUVIMED